Daily non-political popular news in brief.

Tamiflu Significantly Reduces The Risk Of Death From Influenza

10-02-2006 · ScienceDaily

Tamiflu (oseltamivir), is effective in reducing the risk of death associated with seasonal influenza in severely ill patients, according to new data. Treatment of infected adults was associated with a 71 percent reduction in mortality. These results demonstrate the importance of the role of antivirals in the management of seasonal influenza and highlights the seriousness and risk of mortality associated with it.

Keywords: tamiflu, significantly, risk, death, influenza

« Previous | Next »

Similar news on "Tamiflu Significantly Reduces The Risk Of Death From Influenza":

The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, 'Varenicline'
10-31-2006 · EurekAlert!
Smoking is the world's leading cause of premature death. Smokers who quit are able to significantly reduce their risk of premature death and other health issues -- almost completely if they quit by age thirty and by fifty percent if they quit after age fifty. Because it's so difficult to quit smoking, many are turning to smoking cessation drugs, such as varenicline, to help minimize cravings and other withdrawal symptoms.
Similar news · Read more »
Experts predict Tamiflu could halve the pandemic influenza death toll versus no intervention
06-22-2007 · EurekAlert!
Treatment with the oral antiviral Tamiflu (oseltamivir) and prophylaxis for people exposed to infected patients could be one of the most cost-effective strategies for reducing illness and death during an influenza pandemic. According to modelling research presented by Beate Sander, University of Toronto, Canada, a stockpile of Tamiflu sufficient to cover 65 percent of a country's population could cut deaths by approximately half.
Similar news · Read more »
Gene variation may elevate risk of liver tumor in patients with cirrhosis
01-01-2008 · EurekAlert!
A particular gene variation appears to significantly increase the risk that individuals with cirrhosis of the liver will go on to develop hepatocellular carcinoma, a liver tumor that is the third leading cause of cancer death. Researchers from Massachusetts General Hospital Cancer Center and colleagues in France have found that a single alteration in the epidermal growth factor gene may greatly increase the risk that cirrhotic patients will develop the tumor.
Similar news · Read more »
The Journal of Clinical Pharmacology looks at effects of smoking cessation drug, varenicline
10-31-2006 · EurekAlert!
Smoking is the world's leading cause of premature death. Smokers who quit are able to significantly reduce their risk of premature death and other health issues -- almost completely if they quit by age thirty and by fifty percent if they quit after age fifty. Because it's so difficult to quit smoking, many are turning to smoking cessation drugs, such as varenicline, to help minimize cravings and other withdrawal symptoms.
Similar news · Read more »
Early switch to an aromatase inhibitor increases survival
02-12-2007 · EurekAlert!
For breast cancer patients taking tamoxifen, switching to an aromatase inhibitor within three years significantly improves survival rates, according to a new study. The study reveals that the clear survival benefit was also achieved without an increased risk of death from other causes -- a significant risk associated with tamoxifen.
Similar news · Read more »
Gastric bypass reduces mortality risk in severely obese patients
08-22-2007 · EurekAlert!
Severely obese patients who undergo gastric bypass surgery significantly reduce their risk of death from coronary heart disease, diabetes and cancer, according to research published in the Aug. 23, 2007, issue of the New England Journal of Medicine. The study was led by a team of researchers from the University of Utah School of Medicine and LDS Hospital.
Similar news · Read more »
Glycemic control medication appears to have favorable effect regarding risk of cardiovascular events
09-11-2007 · EurekAlert!
A meta-analysis of previous research suggests that use of pioglitazone -- a glycemic control medication for patients with type 2 diabetes -- significantly reduces the risk of heart attack, stroke and death, but increases the risk for serious heart failure, according to an article in the Sept. 12 issue of JAMA.
Similar news · Read more »
Pregnant women with lupus face higher risk of complications and death
11-11-2006 · EurekAlert!
Women with systemic lupus who become pregnant are at significantly greater risk for death or other medical complications than are pregnant women without lupus, Duke University Medical Center researchers have found in a nationwide study of more than 18 million women.
Similar news · Read more »
New research shows that flu is a trigger of heart attacks
04-17-2007 · EurekAlert!
Doctors need to take concerted action to ensure that people who are at risk of heart disease receive the influenza vaccine every autumn, according to the authors of a new report published in the European Heart Journal. Their research shows that influenza epidemics are associated with a rise in deaths from heart disease and that flu can actually trigger the heart attacks that result in death.
Similar news · Read more »
Drug resistance in an influenza pandemic
01-22-2007 · EurekAlert!
Stockpiling large amounts of oseltamivir (Tamiflu) and related antiviral drugs with the intent to treat a large fraction of the population is a key part of pandemic preparedness of many countries. However, it is known that influenza viruses can develop resistance to these drugs. New research suggests that wide-spread use of antiviral drugs during a pandemic carries a substantial risk of resistance emerging and resistant influenza strains causing illness in a substantial number of people.
Similar news · Read more »